NCT03229798View on ClinicalTrials.gov

Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions
Migraine Disorders
Interventions
DRUG

Sumatriptan Succinate Oral Tablet

Sumatriptan succinate commercial Imitrex 100 mg tablet

COMBINATION_PRODUCT

Transdermal delivery of sumatriptan succinate

Sumatriptan succinate transdermal drug delivery system

Trial Locations (1)

27612

Carolina Phase 1 Research, Raleigh

All Listed Sponsors
collaborator

Kimberly-Clark Corporation

INDUSTRY

lead

Sorrento Therapeutics, Inc.

INDUSTRY

NCT03229798 - Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) | Biotech Hunter | Biotech Hunter